Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An instance of focal segmental glomerulosclerosis that is caused by an inherited genomic modification in an individual.
No HPO annotations are available for this condition.
Age of onset: adulthood.
PAX2-related disorder is associated with abnormalities involving the kidneys and/or the eyes. The original PAX2-related disorder known as renal coloboma syndrome is characterized by hypodysplastic kidneys and optic nerve abnormalities (most commonly optic nerve dysplasia) with or without optic nerve or retinal coloboma . Variability. The clinical findings vary even within families, with some family members having either renal manifestations or optic nerve abnormalities and others having both. The severity of renal malformations can range within a family from absence of clinical symptoms to severe fetal renal failure.
Renal coloboma syndrome (or papillorenal syndrome) was the name given to an autosomal dominant condition associated with renal hypodysplasia and abnormalities of the optic nerve and a heterozygous pathogenic variant in PAX2. With improved access to molecular genetic testing, more individuals have been identified and it has become clear that multiple phenotypes beyond that of classic renal coloboma syndrome may be associated with pathogenic variants in PAX2. The authors feel that the term "PAX2-related disorder" best reflects this wide phenotypic variability. There are no formal diagnostic criteria for PAX2-related disorder.
No approved treatments are currently available for inherited focal segmental glomerulosclerosis. The disease remains an area of unmet medical need.
To establish the extent of disease and needs in an individual diagnosed with PAX2-related disorder, the following are recommended if they have not already been completed:
Evaluation of renal structure by renal ultrasound examination
No disease-specific guidelines have been developed. The following ongoing evaluations are recommended in all individuals with PAX2-related disorder.
Follow up by a nephrologist to monitor renal function and blood pressure
Follow up by an ophthalmologist to monitor vision. Any change in vision could indicate a retinal detachment and should be treated as a medical emergency.
Data assembled from 2 of 12 sources · Last updated Oct 4, 2026, 3:03 AM UTC
Source: GeneReviews — "PAX2-Related Disorder"
Source: GeneReviews — "PAX2-Related Disorder"
Table 2. Disorders to Consider in the Differential Diagnosis of PAX2-Related Disorder
Diff Dx Disorder | Gene(s)/Other | MOI | Clinical Features of DiffDx Disorder |
|---|---|---|---|
Kidney | Eye | Distingishing from PAX2-related disorder | — |
CHARGE syndrome1 | CHD72 | AD | Occasional finding: renal anomalies incl dysgenesis, horseshoe/ectopic kidney |
Branchiootorenal syndrome3 | EYA14SIX1 | AD | Oligomeganephronia, renal malformations ranging from mild renal hypoplasia to bilateral renal agenesis, ESRD later in life in some |
Cat-eye syndrome (OMIM 115470) | Tetraploid dosage of proximal 22q | AD | Kidney abnormalities |
PAX6 pathogenic variants(See Aniridia.) | PAX65 | AD | No kidney findings reported |
Joubert syndrome and related disorders (JSRD) | 30 genes | AR6XL | Renal disease in some |
Congenital anomalies of the kidney and urinary tract (CAKUT)8 | 20 genes | ADAR | Renal hypodysplasia / agenesis, vesico-urerteral reflux, cystic dysplasia, ureteropelvic junction obstruction, other urinary tract abnormalities |
Source: GeneReviews — "PAX2-Related Disorder"
Measurement of renal function by serum electrolyte concentrations, BUN, and creatinine
Urinalysis to evaluate for the presence of blood and protein
Evaluation for vesicoureteral reflux, by voiding cystourethrogram (VCUG)
Dilated eye examination
Audiologic assessment (See Genetic Hearing Loss Overview for details of audiologic assessment.)
Consultation with a clinical geneticist and/or genetic counselor
A team approach that includes specialists in ophthalmology, nephrology, audiology, and clinical genetics is recommended. Management is focused on preventing complications of end-stage renal disease (ESRD) and/or vision loss resulting from retinal detachment.
Ongoing treatment of hypertension and/or vesicoureteral reflux (if present) may preserve renal function.
ESRD is treated with renal replacement therapy (i.e., dialysis and/or renal transplantation).
Low vision experts can assist with adaptive functioning of those with significant vision loss.
Prevention of retinal detachment in those with congenital optic nerve abnormalities includes close follow up with an ophthalmologist and use of protective eyewear.
No disease-specific guidelines hav...
Source: GeneReviews — "PAX2-Related Disorder"
Avoid the following:
Use of medications known to affect renal function (requires consultation with a specialist in nephrology)
Contact sports
Source: GeneReviews — "PAX2-Related Disorder"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "PAX2-Related Disorder"
View trials for inherited focal segmental glomerulosclerosis
Audiometric evaluation with periodic follow up
Source: GeneReviews — "PAX2-Related Disorder"